Glenn Liu, MD, is a tenured Professor of Medicine and Medical Physics at the University of Wisconsin (UW)-Madison, and leader of the Developmental Therapeutics Program at the University of Wisconsin Carbone Cancer Center. He is also the Chief of Genitourinary (GU) Oncology and Director of the GU Oncology Research Program at the UW.

Nationally, Dr. Liu is the Prostate Cancer subcommittee chair for the Eastern Cooperative Oncology Group (ECOG), member of the NCI Prostate Cancer Task Force, as well as voting member for the NCI Investigational Drug Steering Committee. Prior awards include several Prostate Cancer Foundation Creativity and Challenge Awards, recipient of NCI Michaele Christian Oncology Drug Development Award and Lectureship, and inclusion in Best Doctors in America.

Dr. Liu has published over 100 manuscripts and book chapters, and has expertise in all phases of clinical trials, biomarker development, and use of molecular imaging in therapy development. He is co-founder of AIQ Solutions, and currently serves as its Chief Medical Officer.

Australian Privacy Policy AIQ's software has been cleared for clinical use under 510(k) K173444. For details, including the applicable Indications for Use, see: